Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Sutro Biopharma Inc shares valued at $60,925 were sold by Vasquez Nicki on Jan 29 ’24. At $5.00 per share, Vasquez Nicki sold 12,185 shares. The insider’s holdings dropped to 12,803 shares worth approximately $62990.76 following the completion of this transaction.
Also, Shtylla Brunilda sold 15,428 shares, netting a total of over 72,595 in proceeds. Following the sale of shares at $4.71 each, the insider now holds 0 shares.
Before that, Shtylla Brunilda had sold 11,613 shares from its account. In a trade valued at $53,282, the Chief Business Officer traded Sutro Biopharma Inc shares for $4.59 each. Upon closing the transaction, the insider’s holdings decreased to 11,613 shares, worth approximately $63605.76.
As published in their initiating research note from Deutsche Bank on November 09, 2023, Sutro Biopharma Inc [STRO] has been a Buy and the price target has been revised to $12. Analysts at Oppenheimer started covering the stock with ‘”an Outperform”‘ outlook in a report released in early October. As of March 21, 2023, Wells Fargo has decreased its “an Overweight” rating to a “an Equal weight” for STRO.
Analyzing STRO Stock Performance
During the last five days, there has been a drop of approximately -0.20%. Over the course of the year, Sutro Biopharma Inc shares have jumped approximately 14.69%. Shares of the company reached a 52-week high of $6.13 on 03/28/24 and a 52-week low of $3.20 on 03/20/24. A 50-day SMA is recorded $4.55, while a 200-day SMA reached $4.05. Nevertheless, trading volume fell to 1.68 million shares from 2.75 million shares the previous day.
Support And Resistance Levels for Sutro Biopharma Inc (STRO)
According to the 24-hour chart, there is a support level at 4.76, which, if violated, would cause prices to drop to 4.60. In the upper region, resistance lies at 5.15. The next price resistance is at 5.39. RSI (Relative Strength Index) is 55.74 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.72, which suggests the price will decrease in the coming days. Percent R is at 41.30%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Sutro Biopharma Inc subject to short interest?
Stocks of Sutro Biopharma Inc saw a sharp steep in short interest on Mar 15, 2024 dropping by -0.35 million shares to 2.32 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 2.67 million shares. A decline of -15.09% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.68 of the overall float, the days-to-cover ratio (short ratio) decline to 2.68.
Which companies own the most shares of Sutro Biopharma Inc (STRO)?
On June 18, 2021, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $35.
